Literature DB >> 12783281

Epidemiology of extended-spectrum beta-lactamases in Sofia, Bulgaria.

G A Jacoby1, R Vacheva-Dobrevsky.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12783281     DOI: 10.1007/s10096-003-0937-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  22 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Plasmid-mediated TEM-3 extended-spectrum beta-lactamase production in Salmonella typhimurium in Casablanca.

Authors:  Rajaa AitMhand; Abdelaziz Soukri; Najat Moustaoui; Hamid Amarouch; Naima ElMdaghri; Danielle Sirot; Mohamed Benbachir
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

3.  Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea.

Authors:  J Kim; Y Kwon; H Pai; J W Kim; D T Cho
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

Authors:  Y De Gheldre; M J Struelens; Y Glupczynski; P De Mol; N Maes; C Nonhoff; H Chetoui; C Sion; O Ronveaux; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

7.  Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia.

Authors:  B Bedenić; C C Randegger; E Stobberingh; H Hächler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

8.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Authors:  G A Jacoby; P Han
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

10.  Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing.

Authors:  T Arstila; G A Jacoby; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

View more
  2 in total

1.  Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

Authors:  George A Jacoby; Kelley E Walsh; Victoria J Walker
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.

Authors:  Minggui Wang; Daniel F Sahm; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.